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ABSTRACT 
Background: Standardised alcohol craving scales are rarely used outside of research 
environments despite recognised clinical utility. Scale length is a key barrier to more 
widespread application. A brief measure of alcohol craving is needed to improve research and 
treatment of Alcohol Use Disorders (AUDs). The Alcohol Craving Experience (ACE) 
questionnaire comprises two 11-item self-report scales based on strong theoretical and 
empirical foundations, which assess past-week frequency and maximum strength of alcohol 
craving. This study aimed to create a brief version of the ACE, while maintaining 
psychometric integrity and clinical utility.  
Methods: Patients attending a university hospital alcohol and drug out-patient service 
for treatment of AUD completed the ACE as part of a questionnaire battery. Three patient 
samples were utilised: 519 patients with pre-treatment and outcome data; 228 patients with 
pre-treatment data; and 66 patients who completed the ACE at treatment sessions one and 
two. Psychometric assessments informing scale reduction and evaluation included predictive, 
construct, concurrent, and convergent validity, as well as internal and test-retest reliability.  
Results: The Frequency version of the ACE was found to have greatest predictive 
utility. Revision of that measure produced a 5-item Mini Alcohol Craving Experience 
(MACE) questionnaire. Levels of predictive, construct, concurrent, and convergent validity 
were maintained in the reduced scale. High internal and test-retest reliability was also 
demonstrated.  
Conclusions: The MACE provides a brief, theoretically and psychometrically robust 
measure of alcohol craving suitable for use with AUD populations in time-limited clinical 
and research settings. 
Keywords: Alcohol Use Disorder, Craving, Urge, Measurement, Scale development
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INTRODUCTION 
Craving is a robust marker of substance dependence severity and is implicated in 
treatment relapse (Flannery et al., 2003; Law et al., 2016). The Diagnostic and Statistical 
Manual of Mental Disorders, Fifth Edition (DSM-5) recently included craving as a diagnostic 
criterion for Substance Use Disorders (American Psychiatric Association, 2013; Hasin et al., 
2013). Craving interventions feature prominently in psychological treatments and  
pharmacotherapies have been developed to target specific craving neuromechanisms 
(Addolorato et al. 2005; Haass-Koffler et al. 2014).  After decades of experimental, clinical, 
and epidemiological research, accurate measurement of substance craving remains a research 
priority (Tiffany and Wray 2012; Kavanagh et al. 2013). Historically, craving has been 
measured by conceptually weak and often unstandardised methods, limiting generalisability 
and clinical utility (Sayette et al. 2000; Pavlick et al. 2009; Kavanagh et al. 2013). Some 
standardised scales have been introduced, although uptake within clinical settings has been 
poor (Pavlick et al. 2009; Tiffany and Wray 2012).  
A national survey of U.S. addiction services found 99% considered craving in 
treatment planning, yet only 5% employed standardised self-report craving measures (Pavlick 
et al. 2009). The majority opted for single-item or non-standard open ended questions, despite 
well documented limitations to the reliability of these approaches (Cortina 1993; Hruschka et 
al., 2004). This may reflect documented psychometric and theoretical weaknesses in self-
report craving scales (Sayette et al. 2000; Kavanagh et al. 2013) and time burden imposed by 
scale administration and analysis in busy clinical environments. Alcohol Use Disorders 
(AUDs) are among the most prevalent Substance Use Disorders, placing a substantial burden 
upon global mortality and disease (Connor and Hall 2015; Gowing et al. 2015; Connor et al. 
2016). A brief, psychometrically sound measure of alcohol craving is needed to improve 
assessment, diagnosis, and treatment of AUDs. 
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Current alcohol craving scales are subject to several common limitations, including: 
administration time, the absence of a coherent theoretical model, poor construct validity due 
to confounding psychological and behavioural constructs, and sub-optimal psychometric 
validation (Abrams 2000; Kavanagh et al. 2013). Reflecting the need for accurate 
measurement of craving, a number of new scales have been proposed: the Yale Craving Scale 
(YCS; Rojewski et al. 2015), a three-item craving measure (McHugh et al. 2016), and the 
Alcohol Craving Experience (ACE) Questionnaire (Statham et al. 2011). When considered 
for application in time limited environments no scale appears suitable. The YCS and ACE are 
limited by administration time. Construct validity of the YCS and McHugh et al.’s (2016) 
scale is restricted by the absence of a theoretical model. McHugh et al.’s (2016) scale also 
contains an item assessing drinking likelihood ("...what is the likelihood that you would drink 
today?"), confounding the validity of the scale as a craving measure. It is proposed that 
reduction of the ACE would result in a theoretically and psychometrically sound measure of 
craving which may be easily integrated in time-limited environments. 
 Reflecting the Elaborated Intrusion (EI) Theory of Desire (Kavanagh et al. 2005; 
May et al. 2014b), the ACE measures three aspects of craving: the intensity of the drive to 
drink (Intensity), the presence of associated imagery (Imagery), and intrusiveness of desire 
cognitions (Intrusion; Statham et al., 2011). EI theory defines craving as an affectively laden 
cognitive event, where an object or activity and its associated pleasure or relief is in focal 
attention (Kavanagh et al. 2005). Consistent with neurobiological models of craving addictive 
substances are believed to recruit the same physiological mechanisms that drive appetitive 
behaviours required for survival (Robinson and Berridge 1993). EI theory proposes that 
biological, environmental, and affective cues trigger intrusive desire-related cognitions which 
occupy attention and prompt elaboration. The subsequent elaboration process—in particular 
imagery—provides momentary pleasure or relief of physical and emotional discomfort 
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(Connor et al. 2014). However, pleasure or relief from elaborative cognitions quickly 
dissipates. Instead, awareness is drawn to any emotional or physical deprivation and to 
potential actions to acquire the target. Further elaboration and intensification of the desire 
ensues, unless the target is acquired or attention is captured elsewhere.  
EI theory aligns with treatment approaches such as motivational enhancement, 
mindfulness, acceptance-based therapies, and retraining attentional biases (Witkiewitz et al. 
2013; May et al. 2014b; Witkiewitz et al. 2014). Recent research has directly employed EI 
theory in the development of promising new craving management strategies and novel 
treatment approaches  ( Kemps and Tiggemann 2007; Knäuper et al. 2011; Kemps and 
Tiggemann 2013; Hsu et al. 2014; Skorka-Brown et al. 2014; Littel et al. 2016). These 
approaches employ non-substance imagery and sensory tasks designed to compete with 
craving-based imagery within the limited capacity of working memory. The information 
provided by the ACE, in conjunction with EI theory, may facilitate more detailed 
formulation, treatment planning, and monitoring of craving.   
The ACE was originally developed in an AUD sample (Statham et al. 2011), to 
measure the frequency (ACE-F) and peak strength (ACE-S) of alcohol craving over the 
previous week. Exploratory and confirmatory factor analysis showed that the items in both 
forms of the ACE cluster into three distinct factors consistent with EI theory: Intensity, 
Imagery, and Intrusion of craving-related cognitions. The ACE has high internal reliability 
and significantly correlates with the Obsessive Compulsive Drinking Scale (OCDS), Alcohol 
Use Disorders Identification Test (AUDIT), as well as measures of psychological distress 
highly comorbid with AUDs. The ACE has further been demonstrated to discriminate non-
clinical from clinical samples (Statham et al. 2011). May and colleagues (2014) pooled 12 
studies using modified forms of the ACE to assess craving across a range of substances, 
including alcohol (May et al. 2014a). The original factor structure was replicated across all 
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substances.  
The ACE provides a theoretically grounded, psychometrically robust measure, with 
strong rationale for more effectively targeting alcohol craving interventions, and has shown 
its value in research settings. For clinical settings, however, the full ACE is both repetitive 
(with each item appearing in both the Strength and Frequency forms) and time consuming. A 
shorter version of the ACE is likely to result in higher uptake, especially where repeated 
administration is required. The aim of this study is to develop a short form of the ACE for use 
in treatment planning and outcome assessment without compromising its theoretical 
foundation or psychometric integrity.  
MATERIALS AND METHODS 
Participants 
Three samples of data were drawn from patients attending a metropolitan university 
hospital alcohol and drug out-patient service. The service comprises eight sessions of 
Cognitive Behaviour Therapy (CBT) conducted over 12 weeks. Treatment may be 
supplemented by pharmacotherapy (naltrexone, acamprosate or both). The assessment battery 
is completed in a separate consultation prior to the first treatment session, and again at the 
completion of treatment. All patients were over 18 years of age and met DSM-IV (American 
Psychiatric Association 2000) criteria for alcohol dependence. Human ethics approval was 
obtained (2008/125, HREC/12/QPAH/022 HREC/14/QPAH/664) and participants provided 
informed written consent. Sample characteristics are presented in Table 1.  
 
Scale Reduction Sample. This sample comprised 519 alcohol dependent patients 
(Table 1). All patients were over 18 years of age and met DSM-IV(American Psychiatric 
Association 2000) criteria for alcohol dependence. These data have been used previously in 
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the original development of the ACE (Statham et al. 2011) and in examining craving as a 
mediator of change (Law, et al., 2016), but have not been used to directly predict treatment 
outcome.  
 
Validation Sample. The validation sample comprised pre-treatment data from 228 
consecutively treated alcohol dependent patients (Table 1). These data were employed to 
assess the factor structure of the ACE scales and cross-sectional relationships between 
variables. 
 
Test-Retest (TRT) Sample. The ACE-F was administered to 66 patients at treatment 
sessions 1 and 2, in-order to assess test-retest reliability of the ACE-F. Mean time between 
sessions was 8.40 days (SD = 2.86).  
 
Insert Table 1 
 
 
Measures 
The Alcohol Craving Experience (ACE) questionnaire. The ACE comprises two 11-
item questionnaires that assess the frequency (ACE-F) or peak strength (ACE-S) of desire-
related cognitions over the previous week. Items load onto three classes of cognition, 
‘Intensity’ (items 1-3), ‘Imagery’ (items 4-8), and ‘Intrusion’ (items 9-11). Participants 
respond via an 11-point visual analogue scale with anchors 0 (not at all) and 10 
(constantly/extremely). The ACE-F and ACE-S have good internal reliability and concurrent 
validity, and can discriminate between problem and non-problem drinkers (Statham et al. 
2011).  
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The Obsessive Compulsive Drinking Scale (OCDS). The OCDS is a 14-item self-
report measure intended to reflect drinking-related obsessive and compulsive craving and 
behaviour (Anton et al., 1995). The OCDS has acceptable test-retest reliability, internal 
reliability, and concurrent validity (Anton et al., 1995; Kranzler et al., 1999; Roberts et al., 
1999). The first six items comprise the Obsessions Subscale (OBS), and are intended to 
assess drinking obsession related cognitions. As an assessment of pure craving the OBS has 
the greatest construct validity within the OCDS (Kavanagh et al. 2013).  The remaining 
items, originally intended to reflect drinking compulsions, assess extraneous constructs such 
as consumption and interference with functioning. The OBS was utilised as a concurrent 
measure of craving. 
 
The Alcohol Use Disorders Identification Test (AUDIT). The AUDIT is a 10-item, 
self-report measure assessing recent alcohol use, symptoms of alcohol dependence, and 
alcohol related problems (Saunders et al. 1993). The AUDIT has sound internal reliability, 
sensitivity and specificity, and discriminant validity (Saunders et al. 1993). Higher scores 
indicate increased risk of harmful or hazardous drinking. 
 
The Beck Depression Inventory - Second Edition (BDI-II). The BDI-II is a 21-item 
self-report measure assessing attitudes and behaviours symptomatic of depression (Beck et al. 
1996). The BDI-II is a well validated measure demonstrating strong test-retest and internal 
reliability, as well as good concurrent, content, discriminant, and construct validity (Beck et 
al. 1988; Beck et al. 1996).  
 
The State Anxiety Scale (S-Anxiety). The S-Anxiety Scale of the State Trait Anxiety 
Inventory (STAI) comprises 20 self-report items assessing the respondent’s current state of 
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anxiety (Spielberger 1983). The S-Anxiety has acceptable internal and test-retest reliability, 
as well as content, discriminant, and construct validity (Spielberger 1983; Oei et al. 1990; 
Barnes et al. 2002).  
 
Procedure 
Scale Reduction. To best maintain consistency of the measured construct, an initial 
step involved selection of a form of the ACE for further refinement (ACE-F or ACE-S). Each 
form was evaluated based on perceived clinical utility and predictive validity. Decisions 
guiding subsequent item reduction were driven by: (a) face validity and theoretical 
importance within EI theory; (b) the endorsement of each item within the alcohol dependent 
sample; (c) the capacity for each item to discriminate between patients who lapsed or 
withdrew from treatment and those who were abstinent throughout treatment; and (d) the 
contribution of each item to a model predicting abstinent completion of treatment. Data 
analyses within this step utilised the Scale Reduction Sample. 
 
Scale Evaluation. Reduced models were further evaluated based on construct, 
concurrent, and convergent validity, as well as internal and test-retest reliability. Data 
analysis within this step utilised the Validation and Test-Retest samples. 
 
Scale Selection. The shortest scale maintaining psychometric integrity would be 
selected as the final reduced version.  
 
Data Analysis 
Analyses were conducted in SPSS version 22. Confirmatory factor analyses (CFA) 
were conducted in R version 3.2.1(R Core Team 2015), package extension lavaan .5-18  
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(Rosseel 2012). As the distributions of all ACE item and scale scores were significantly 
negatively skewed, statistical procedures robust to non-normal distributions were utilised. 
 
RESULTS 
Scale Reduction 
Subscale-Selection. As the ACE-S asks the respondent to report on only the most 
severe episode of past week craving, it is highly susceptible to contextual factors such as 
situational cues and novel stressors. Clinical value of this method is drawn from the isolation 
of a specific time-period where the patient may be most vulnerable to lapse. Alternatively, the 
ACE-F assesses the perceived frequency of craving symptoms over the past week, providing 
a more general overview of the patients craving experience. The ACE-F was subsequently 
identified as the preferred scale for reduction, based on its perceived benefit as a measure 
more sensitive to change in the patient’s typical craving experience.  
Using the Scale Reduction Sample, separate logistic regression analyses were 
employed to assess the capacity of each scale to predict the likelihood of treatment lapse or 
dropout, relative to patients who were abstinent throughout treatment. AUDIT scores and 
medication status were included as covariates, but did not significantly improve upon the 
intercepts-only model (Δχ2 (2) = 1.89, p = .910, Nagelkerke R2 = .001). Inclusion of either the 
ACE-S (Δχ2 (1) = 17.80, p = <.001, Nagelkerke R2 = .053) or ACE-F (Δχ2 (1) = 21.89, p = 
<.001, Nagelkerke R2 = .065) significantly improved the predictive power of the model. 
When both measures were entered, ACE-F was the dominant predictor (β=.015, p=.039), 
while additional variance explained by the ACE-S was non-significant due to high covariance 
between the scales (β =.004, p=.525; Δχ2 (4) = 22.22, p = <.001, Nagelkerke R2 = .065). The 
ACE-F was therefore selected for further refinement. 
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Item Importance. Prior to item reduction, the structure and items central to the 
theoretical foundation of the scale were considered. At least one item from each sub-scale 
was retained to represent each factor. Items 3 and 9 (Table 2) were prioritized for retention 
due to high semantic consistency to the Intensity and Intrusion factors respectively. Multiple 
items of the Imagery factor were retained to capture potential individual differences in the 
most prevalent imagery modalities involved in alcohol craving.  
 
Feature Prevalence. Medians and interquartile ranges for all ACE-F items are 
presented in Table 2. While all items had an interquartile range of at least 4 on the 11-point 
scale, most also received a large proportion of ‘not at all’ responses. To identify which items 
were most representative of common craving symptoms among patients with AUD, the 
endorsement rates (proportion of non-zero responses to each item) were also calculated. 
McNemar’s χ2 was utilised to identify significant differences between items in the prevalence 
of endorsement rates within each factor. Within the Intensity factor, the endorsement rate of 
Item 2 (80.2%) was significantly lower than Item 3 (86.1%), while Items 1 (87.6%) and 3 
could not be distinguished (p = .169). Comparisons of endorsement rates of items within the 
Imagery factor revealed all were significantly different (p<.001), with the exception of the 
two most highly endorsed (Items 4 and 8; p=.716).  Within the Intrusion factor, item 11 was 
the least endorsed factor (75.8%, p<.001) while items 9 (84.9%) and 10 (83.8%) could not be 
differentiated (p=.291).  
 
Insert Table 2 
 
Separate Mann-Whitney U tests revealed that the mean rank of patients who lapsed or 
withdrew from treatment was significantly higher for every item than those who completed 
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treatment abstinent (Table 3). Steiger’s Z revealed no significant differences in the size of the 
effects between items.  
 
Insert Table 3 
 
Item Reduction. Items with the highest endorsement rates were given greater priority 
for retention to reduce the number of ‘not at all’ responses within the reduced scale. Based on 
symptom prevalence and consistency with the overarching factors, items 3 and 9 were 
retained to represent the Intensity and Intrusion factors respectively. The three imagery items 
with the highest endorsement rates (4, 5, and 8) were retained to comprise the initial Imagery 
factor.  
A sequential logistic regression was employed to assess the capacity for the selected 
items to predict alcohol lapse in the Scale Reduction Sample. The AUDIT score and 
prescription of anti-craving medication were again included in the baseline model. Inclusion 
of the items intended to comprise the reduced ACE (items 3, 4, 5, 8, 9) significantly 
improved the predictive power of the model above the AUDIT and medication (Δχ2 (5) = 
19.50, p =.002, Nagelkerke R2 = .065). To assess whether the model could be improved with 
the inclusion of additional ACE items, the remaining items were included using forward 
entry. This indicated that the sequential inclusion of items 1 (Δχ2 (1) = 8.82, p =.003, 
Nagelkerke R2 = .085) and 10 (Δχ2 (1) = 8.79 p =.003) would significantly improve the final 
model (Δχ2 (9) = 37.192, p <.001, Nagelkerke R2 = .110). 
 
Scale Evaluation 
Validity. To assess the construct validity of the initial five-item scale, the seven-item 
scale, and the complete ACE-F, confirmatory factor analyses were performed utilising the 
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Validation Sample. Maximum likelihood estimation with robust standard errors and a 
Satorra-Bentler scaled test statistic were employed to reduce the effects of non-normality. For 
the 11 and 7 item scales, the three-factor solution provided a better fit to the data than a 
unifactorial model (Table 4). For the five item scale, both solutions showed comparable fit. 
These results support previous studies validating the three-factor structure of the ACE 
(Statham et al. 2011; May et al. 2014a), though when reduced to a five-item scale, it could 
equally reflect a global construct of craving within a single factor.  
 
Insert Table 4 
 
All scales had large positive correlations with the OBS, indicating an acceptable level 
of concurrent validity (Table 5). Convergent validity was demonstrated by small to moderate 
positive correlations with the AUDIT and moderate correlations with measures of 
psychological distress (STAI and BDI). The strength of the correlations did not significantly 
differ between the three ACE versions (Steiger’s Z >.05) indicating that convergent and 
concurrent validity of the ACE was not significantly affected by scale reduction.  
 
Insert Table 5 
 
Reliability. Internal consistency was assessed using the Validation Sample. Reliability 
of all scales and subscales was strong, with only minor reductions within the reduced scales 
(Table 6). Test-Retest reliability utilised session one and two data from 66 patients. 
Correlations between session one and session two ACE scores indicated that test-retest 
reliability was acceptable across all scales (Table 6). Steiger’s Z revealed no significant 
changes in scale test-retest reliability following reduction. 
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Insert Table 6 
 
Scale Selection  
The procedures conducted indicate that the ACE-F may be reduced to as few as five items 
while maintaining theoretical and psychometric integrity. The five-item scale, termed the 
Mini Alcohol Craving Experience (MACE), was chosen as the most suitable short-form scale 
for assessment of craving in AUD populations.  
 
DISCUSSION 
In place of the two 11–item forms of the ACE, a brief five-item measure of craving 
was validated (MACE). The MACE maintained high construct, predictive, concurrent, and 
convergent validity.  High internal and test-retest reliability consistent with the ACE-F was 
also demonstrated. The MACE measures the frequency of past week craving including 
intense urges, imagery, and intrusiveness of craving related cognitions (Kavanagh et al., 
2005). The MACE is simple to administer and may be completed in less than 60 seconds, 
reducing time burden on respondents, health professionals, and researchers. 
In addition to its brevity, the MACE maintains several strengths uncommon among 
current craving instruments, including a strong theoretical model and absence of drinking 
constructs known to confound craving measurement (Kavanagh et al., 2013; Sayette et al., 
2000). By retaining the items most representative of the ACE factors, and monitoring the 
resultant model fit, the MACE preserved the construct validity of the ACE. The MACE 
subsequently retains the capacity for unique insight into intensity and intrusiveness of patient 
craving, as well as the prevalence of craving based imagery. This information may inform 
case formulation and treatment planning.   
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Predictive validity is infrequently examined in existing craving measures. Higher 
scores on the MACE was predictive of increased risk of lapse or dropout from treatment in 
this alcohol dependent sample. The MACE may therefore assist addiction professionals to 
better assess risk of relapse in their patients.  
Few craving measures assess test-retest reliability. The MACE deliberately measures 
past week frequency of craving, under the assumption that this will have greater stability and 
subsequently be a more reliable indicator of change than single time point assessments. The 
correlation of session one and two MACE scores was r = .73, and is interpreted as an 
acceptable degree of stability within the clinical context. Given the prominence of craving 
within clinical and research settings, a measure of craving sensitive to change over time is 
greatly needed. The MACE may enhance the validity of studies assessing the efficacy of 
craving interventions, and improve monitoring of patients’ treatment response in clinical 
settings.  
As this study was conducted in a hospital outpatient clinic, the samples provided 
optimal, clinically relevant data. However, the practical nature of the research design 
introduced some limitations. The samples predominantly comprised middle-aged men with 
poor social or occupational functioning and moderate to severe alcohol dependence. Future 
studies should investigate the MACE in more diverse patient populations, as craving profiles 
may vary across problem severity, age, culture, social-occupational status. An additional 
limitation is that follow up data of patients who dropped out were not available.  and were 
conservatively recorded as having lapsed. Assessment of test-retest reliability was also 
impaired by the treatment setting. An increased focus on drinking and attempts to change 
drinking behaviours is likely to have increased variance in patient craving from session one to 
two. While this is hypothesised to have led to the underestimation of the MACE’s stability, 
future research should assess participants under stable conditions with tightly controlled time 
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points. Finally, while craving frequency presents ongoing challenges to the control of 
drinking, very intense peak levels also constitute significant risk. Utilising both frequency 
and strength forms of the ACE is recommended when time permits, as they offer a more 
comprehensive assessment of the patient’s experience of craving. All ACE scales, scoring 
instructions, and normative data are included in the online supplementary material. 
The Mini Alcohol Craving Experience (MACE) reflects the key theoretical elements 
of the ACE, while maintaining the best performing items and preserving psychometric 
integrity. Key strengths of the MACE include excellent construct validity, predictive validity, 
and acceptable test-retest reliability. In conjunction with its brevity, these features make the 
MACE ideal for use with AUD populations in time limited clinical and research 
environments.  
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Table 1. Patient sample characteristics 
Sample characteristics Scale Reduction Sample Validation Sample TRT Sample 
  n = 519 n = 228 n = 66 
Mean Age, years (SD) 39.82 (11.59) 44.39 (10.82) 45.48 (10.03) 
Sex, female 171 (32.9%) 84 (36.8%) 22 (33.3) 
Married/De-facto 184 (35.5%%) 82 (36.0%) 25 (37.9%) 
Education    
   Degree 70 (13.5%) 47 (20.5%) 17 (25.8%) 
   Diploma/Certificate 52 (10.0%) 16 (7.1%) 6 (9.1%) 
   Senior Secondary (Year 12) 157 (30.3%) 71 (31.1%) 22 (33.3%) 
   Junior Secondary (Year 10) 190 (36.6%) 82 (36.0%) 17 (25.8%) 
   Primary (Year 7) 33 (6.4%) 11 (4.8%) 4 (6.1%) 
Unemployed 103 (19.8%) 44 (19.3%) 15 (22.7%) 
Mean Alcohol (grams) per drinking day (SD) 147.07 (88.90) 169.80 (100.93) 196.12 (119.71) 
Median Baseline ACE-F (IQR) 39 (48.00) 42.00 (46.75) 43.50 (45.50) 
Mean Baseline AUDIT (IQR) 27.25 (8.6) 29.38 (7.01) 27.47 (10.28) 
Medication Prescribed* 315 (60.7%) 25 (11.0%) 10 (15.2%) 
*The Scale Reduction Sample records medication (naltrexone/acamprosate/both) if it is prescribed at any point during treatment. Medication is 
only counted in the Validation and TRT samples if it was taken in the week prior to assessment. As the Validation sample assessment occurred 
prior to commencement of behavioural treatment and TRT sample was assessed in Session 1, the majority of patients had not yet been prescribed 
pharmacotherapy.  
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Table 2. Percentiles, Interquartile Ranges, and Endorsement Rates (ER) of ACE-F Items.  
    Percentile    
How often did these things happen over the last week? n 25 50 75 IQR ER (%) 
1.  Did you want a drink? 518 2 5 7 5 87.6 
2.  Did you think about needing a drink? 519 1 3 7 6 80.2 
3.  Did you have an urge to drink? 519 2 5 8 6 86.1 
4.  Did you picture alcohol or drinking? 519 1 3 6 5 80.9 
5.  Did you imagine what it would taste like? 518 0 2 6 6 73.0 
6.  Did you imagine what it would smell like? 519 0 1 4 4 61.3 
7.  Did you imagine what it would feel like in your mouth or throat? 519 0 2 5 5 67.1 
8.  Did you imagine how your body would feel if you had a drink? 518 1 4 7 6 80.1 
9.  When you thought about alcohol over the last week, how often 
were the thoughts intrusive? 507 1 4 7 6 84.9 
10.  When you thought about alcohol over the last week, how often 
were you trying not to think about alcohol? 517 1 5 8 7 83.8 
11.  Did you find it hard to think about anything else? 516 1 2 5 4 75.8 
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Table 3. Mean rank comparison of abstinent patients and those who lapsed or dropped out of treatment across all ACE-F items scores.  
  Complete Abstinent 
Lapse or 
Dropout         
How often did these things happen over the last week? n Mean Rank n 
Mean 
Rank U Z p r 
1.  Did you want a drink? 118 196.24 398 276.96 16135.00 -5.19 <.001 -0.23 
2.  Did you think about needing a drink? 118 203.00 399 275.56 16933.00 -4.67 <.001 -0.20 
3.  Did you have an urge to drink? 118 203.95 399 275.28 17045.00 -4.58 <.001 -0.20 
4.  Did you picture alcohol or drinking? 118 215.42 399 271.89 18398.50 -3.64 <.001 -0.16 
5.  Did you imagine what it would taste like? 118 215.79 398 271.16 18442.50 -3.59 <.001 -0.16 
6.  Did you imagine what it would smell like? 118 217.61 399 271.24 18656.50 -3.54 <.001 -0.16 
7.  Did you imagine what it would feel like in your mouth or 
throat? 118 214.71 399 272.10 18315.00 -3.74 <.001 -0.16 
8.  Did you imagine how your body would feel if you had a 
drink? 118 223.04 398 269.01 19298.00 -2.96 0.003 -0.13 
9.  When you thought about alcohol over the last week, how 
often were the thoughts intrusive? 117 223.46 388 261.91 19241.50 -2.51 0.012 -0.11 
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Table 4. Robust fit indices for the 3-factor and unifactorial structures of the ACE scales (n = 228). 
 Scale χ2 (df) χ2 /df p CFI RMSEA SRMR AIC 
ACE-F 11       
  Unifactorial 302.13 (44) 6.87 <.001 0.898 0.160 0.069 11236.7 
  3-Factor 158.92 (41) 3.88 <.001 0.954 0.112 0.056 11013.50 
ACE-F 7       
  Unifactorial 78.91 (14) 5.64 <.001 0.955 0.143 0.040 7321.29 
  3-Factor 35.59 (11) 3.24 <.001 0.983 0.099 0.027 7265.35 
ACE-F 5       
  Unifactorial 13.72 (5) 2.74 0.017 0.988 0.087 0.031 5410.49 
  3-Factor 13.07 (4) 3.27 0.011 0.987 0.100 0.030 5412.35 
 
  
10.  When you thought about alcohol over the last week, how 
often were you trying not to think about alcohol? 117 211.29 398 271.73 17818 -3.88 <.001 -0.17 
11.  Did you find it hard to think about anything else? 118 203.59 399 275.56 17003 -4.55 <.001 -0.20  
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Table 5. Correlations between the ACE-F scales and the OBS, OCDS, AUDIT, S-Anxiety, and BDI 
  OBS OCDS Total AUDIT S-Anxiety BDI 
ACE-F 11 .598*** .547*** .215*** .381*** .380*** 
ACE-F 7 .585*** .543*** .196** .401*** .388*** 
ACE-F 5 .583*** .542*** .211*** .385*** .382*** 
**p<.01, ***p<.001 
 
Table 6. Cronbach’s alphas and correlations between session one and two ACE scale scores.  
  α  r 
ACE-F 11 0.946 .731*** 
  Intensity 0.940 .718*** 
  Imagery 0.917 .741*** 
  Intrusion 0.807 .636*** 
ACE-F 7 0.919 .725*** 
  Intensity 0.908 .672*** 
  Imagery 0.866 .732*** 
  Intrusion 0.641 .632*** 
ACE-F 5 0.922 .728*** 
 
 
